MedPath

Effect of Glucosamine Sulfate, Chondrotin Sulfate, Methylsulfonylmethane Phonophoresis on Pain, Range of Motion, Position Sense and function in Knee Osteoarthritis

Phase 3
Conditions
Musculoskeletal Diseases
Registration Number
PACTR20180770451482
Lead Sponsor
Soheir
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
All
Target Recruitment
70
Inclusion Criteria

Eligibility was defined as symptomatic knee OA for at least 6 months according to the clinical criteria of the American College of Rheumatology (ACR)
Radiographic confirmed knee OA according to the Kellgren & Lawrence scale

Exclusion Criteria

Exclusion criteria included acute septic arthritis;
inflammatory arthritis;
any other type of arthritis;
history of knee buckling or recent knee injury;
lack of physical or mental ability to perform or comply with the treatment procedure;
diabetes mellitus;
fibromyalgia or other chronic pain syndromes;
concurrent anti-coagulant/anti-platelet drugs;
arthroscopy or intra-articular injections in the previous 3 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath